samedan logo
 
 
spacer
home > pmps > spring 2007 > lifting the lid on induction sealing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Lifting the Lid on Induction Sealing

Due to a number of developments since its inception, induction sealing now offers greater productivity and control, and the ability to incorporate anti-tampering and anti-counterfeiting methods. Peter Tindale at Pillar Technologies breaks open the advantages over competing technologies

Induction sealing is a straightforward process used in the pharmaceutical packaging industry and many other technically demanding applications as a method of hermetically sealing containers with a foil laminate. The induction liner comprises an aluminium foil with a heatseal facing and other layers according to the requirements of the application. This is typically supplied already inserted into the closure. The torqued-down closure and container are then passed under an induction sealing head where an electromagnetic field induces a current into the foil which, in turn, generates heat. This is sufficient to melt the heat-seal layer on the underside of the foil, and form a strong bond.

The result is a truly hermetic seal, with excellent moisture and oxygen barrier properties, capable of providing secondary tamper evidence, extending product shelf-life and eliminating the risk of leakages. Perhaps just as importantly, this can be achieved quickly, simply and safely on plastic or glass containers at high line speeds – typically over 100 containers/minute – and without the need for any form of contact between the sealing head and the container.

THE BENEFITS OF INDUCTION

Adding induction sealing to an existing production line is inexpensive and offers a potentially rapid return on investment. In comparison with conduction sealing techniques, induction is a much more efficient and controlled process, with instant start-up. Unlike conduction, which uses a hot plate process, induction uses an electromagnetic field to generate heat so that ambient heat is minimised, helping to keep the sealing head at a cool temperature, improving operator safety and simultaneously offering a wider selection of lining materials to choose from. In addition, applications for conduction can be limited if the product to be packaged has particularly heat-sensitive constituents.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
4
     

There are no comments in regards to this article.

spacer
Peter Tindale has a Degree in Modern Languages and a Post Graduate Certificate in Export Sales and Marketing Management. He has held the position of Product Manager for Pillar Technologies for two years. Peter is responsible for the Pillar brand in Europe and was previously with fellow ITW company Unipac, where he held the position of International Sales Manager for more than five years, working in China and South East Asia before becoming focused on European sales.
spacer
Peter Tindale
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Inaugural Conference on Pre-Filled Syringes

21-22 January 2009, Crowne Plaza Hotel - St James, London, UK

SMi present their Inaugural Conference on Pre-Filled Syringes 21st and 22nd January 2009 at the Crowne Plaza Hotel - St James, London, UK
More info >>

 
News and Press Releases

Azopharma Product Development Group, Inc

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement